Global Injection Influenza Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Injection Influenza Vaccine market size was valued at US$ 7468.9 million in 2023. With growing demand in downstream market, the Injection Influenza Vaccine is forecast to a readjusted size of US$ 10860 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Injection Influenza Vaccine market. Injection Influenza Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Injection Influenza Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Injection Influenza Vaccine market.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Injection Influenza Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Injection Influenza Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Injection Influenza Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Injection Influenza Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Injection Influenza Vaccine industry. This include advancements in Injection Influenza Vaccine technology, Injection Influenza Vaccine new entrants, Injection Influenza Vaccine new investment, and other innovations that are shaping the future of Injection Influenza Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Injection Influenza Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Injection Influenza Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Injection Influenza Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Injection Influenza Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Injection Influenza Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Injection Influenza Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Injection Influenza Vaccine market.
Market Segmentation:
Injection Influenza Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Injection Influenza Vaccine market?
What factors are driving Injection Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injection Influenza Vaccine market opportunities vary by end market size?
How does Injection Influenza Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Injection Influenza Vaccine market size was valued at US$ 7468.9 million in 2023. With growing demand in downstream market, the Injection Influenza Vaccine is forecast to a readjusted size of US$ 10860 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Injection Influenza Vaccine market. Injection Influenza Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Injection Influenza Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Injection Influenza Vaccine market.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Injection Influenza Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Injection Influenza Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Injection Influenza Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Injection Influenza Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Injection Influenza Vaccine industry. This include advancements in Injection Influenza Vaccine technology, Injection Influenza Vaccine new entrants, Injection Influenza Vaccine new investment, and other innovations that are shaping the future of Injection Influenza Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Injection Influenza Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Injection Influenza Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Injection Influenza Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Injection Influenza Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Injection Influenza Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Injection Influenza Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Injection Influenza Vaccine market.
Market Segmentation:
Injection Influenza Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Jiangsu GDK
- KM Biologics
What is the 10-year outlook for the global Injection Influenza Vaccine market?
What factors are driving Injection Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injection Influenza Vaccine market opportunities vary by end market size?
How does Injection Influenza Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injection Influenza Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Injection Influenza Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Injection Influenza Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Injection Influenza Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Injection Influenza Vaccine Sales by Type
2.3.1 Global Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Injection Influenza Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Injection Influenza Vaccine Sale Price by Type (2019-2024)
2.4 Injection Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Injection Influenza Vaccine Sales by Application
2.5.1 Global Injection Influenza Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Injection Influenza Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Injection Influenza Vaccine Sale Price by Application (2019-2024)
3 GLOBAL INJECTION INFLUENZA VACCINE BY COMPANY
3.1 Global Injection Influenza Vaccine Breakdown Data by Company
3.1.1 Global Injection Influenza Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Injection Influenza Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Injection Influenza Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Injection Influenza Vaccine Revenue by Company (2019-2024)
3.2.2 Global Injection Influenza Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Injection Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Injection Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injection Influenza Vaccine Product Location Distribution
3.4.2 Players Injection Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTION INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Injection Influenza Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Injection Influenza Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Injection Influenza Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Injection Influenza Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Injection Influenza Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Injection Influenza Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Injection Influenza Vaccine Sales Growth
4.4 APAC Injection Influenza Vaccine Sales Growth
4.5 Europe Injection Influenza Vaccine Sales Growth
4.6 Middle East & Africa Injection Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Injection Influenza Vaccine Sales by Country
5.1.1 Americas Injection Influenza Vaccine Sales by Country (2019-2024)
5.1.2 Americas Injection Influenza Vaccine Revenue by Country (2019-2024)
5.2 Americas Injection Influenza Vaccine Sales by Type
5.3 Americas Injection Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injection Influenza Vaccine Sales by Region
6.1.1 APAC Injection Influenza Vaccine Sales by Region (2019-2024)
6.1.2 APAC Injection Influenza Vaccine Revenue by Region (2019-2024)
6.2 APAC Injection Influenza Vaccine Sales by Type
6.3 APAC Injection Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injection Influenza Vaccine by Country
7.1.1 Europe Injection Influenza Vaccine Sales by Country (2019-2024)
7.1.2 Europe Injection Influenza Vaccine Revenue by Country (2019-2024)
7.2 Europe Injection Influenza Vaccine Sales by Type
7.3 Europe Injection Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injection Influenza Vaccine by Country
8.1.1 Middle East & Africa Injection Influenza Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Injection Influenza Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Injection Influenza Vaccine Sales by Type
8.3 Middle East & Africa Injection Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injection Influenza Vaccine
10.3 Manufacturing Process Analysis of Injection Influenza Vaccine
10.4 Industry Chain Structure of Injection Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injection Influenza Vaccine Distributors
11.3 Injection Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR INJECTION INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Injection Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Injection Influenza Vaccine Forecast by Region (2025-2030)
12.1.2 Global Injection Influenza Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injection Influenza Vaccine Forecast by Type
12.7 Global Injection Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Injection Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Injection Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Injection Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Injection Influenza Vaccine Product Portfolios and Specifications
13.4.3 Viatris Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Injection Influenza Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Injection Influenza Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Injection Influenza Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Injection Influenza Vaccine Product Portfolios and Specifications
13.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Injection Influenza Vaccine Product Portfolios and Specifications
13.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injection Influenza Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Injection Influenza Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Injection Influenza Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Injection Influenza Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Injection Influenza Vaccine Sales by Type
2.3.1 Global Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Injection Influenza Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Injection Influenza Vaccine Sale Price by Type (2019-2024)
2.4 Injection Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Injection Influenza Vaccine Sales by Application
2.5.1 Global Injection Influenza Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Injection Influenza Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Injection Influenza Vaccine Sale Price by Application (2019-2024)
3 GLOBAL INJECTION INFLUENZA VACCINE BY COMPANY
3.1 Global Injection Influenza Vaccine Breakdown Data by Company
3.1.1 Global Injection Influenza Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Injection Influenza Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Injection Influenza Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Injection Influenza Vaccine Revenue by Company (2019-2024)
3.2.2 Global Injection Influenza Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Injection Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Injection Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injection Influenza Vaccine Product Location Distribution
3.4.2 Players Injection Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTION INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Injection Influenza Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Injection Influenza Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Injection Influenza Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Injection Influenza Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Injection Influenza Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Injection Influenza Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Injection Influenza Vaccine Sales Growth
4.4 APAC Injection Influenza Vaccine Sales Growth
4.5 Europe Injection Influenza Vaccine Sales Growth
4.6 Middle East & Africa Injection Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Injection Influenza Vaccine Sales by Country
5.1.1 Americas Injection Influenza Vaccine Sales by Country (2019-2024)
5.1.2 Americas Injection Influenza Vaccine Revenue by Country (2019-2024)
5.2 Americas Injection Influenza Vaccine Sales by Type
5.3 Americas Injection Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injection Influenza Vaccine Sales by Region
6.1.1 APAC Injection Influenza Vaccine Sales by Region (2019-2024)
6.1.2 APAC Injection Influenza Vaccine Revenue by Region (2019-2024)
6.2 APAC Injection Influenza Vaccine Sales by Type
6.3 APAC Injection Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injection Influenza Vaccine by Country
7.1.1 Europe Injection Influenza Vaccine Sales by Country (2019-2024)
7.1.2 Europe Injection Influenza Vaccine Revenue by Country (2019-2024)
7.2 Europe Injection Influenza Vaccine Sales by Type
7.3 Europe Injection Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injection Influenza Vaccine by Country
8.1.1 Middle East & Africa Injection Influenza Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Injection Influenza Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Injection Influenza Vaccine Sales by Type
8.3 Middle East & Africa Injection Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injection Influenza Vaccine
10.3 Manufacturing Process Analysis of Injection Influenza Vaccine
10.4 Industry Chain Structure of Injection Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injection Influenza Vaccine Distributors
11.3 Injection Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR INJECTION INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Injection Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Injection Influenza Vaccine Forecast by Region (2025-2030)
12.1.2 Global Injection Influenza Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injection Influenza Vaccine Forecast by Type
12.7 Global Injection Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Injection Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Injection Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Injection Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Injection Influenza Vaccine Product Portfolios and Specifications
13.4.3 Viatris Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Injection Influenza Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Injection Influenza Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Injection Influenza Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Injection Influenza Vaccine Product Portfolios and Specifications
13.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Injection Influenza Vaccine Product Portfolios and Specifications
13.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Injection Influenza Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Injection Influenza Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Injection Influenza Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Injection Influenza Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Injection Influenza Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Injection Influenza Vaccine Revenue by Application (2019-2024)
Table 13. Global Injection Influenza Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Injection Influenza Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Injection Influenza Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Injection Influenza Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Injection Influenza Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Injection Influenza Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Injection Influenza Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Injection Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Injection Influenza Vaccine Products Offered
Table 22. Injection Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Injection Influenza Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Injection Influenza Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Injection Influenza Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Injection Influenza Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Injection Influenza Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Injection Influenza Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Injection Influenza Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Injection Influenza Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Injection Influenza Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Injection Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Injection Influenza Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Injection Influenza Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Injection Influenza Vaccine
Table 58. Key Market Challenges & Risks of Injection Influenza Vaccine
Table 59. Key Industry Trends of Injection Influenza Vaccine
Table 60. Injection Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Injection Influenza Vaccine Distributors List
Table 63. Injection Influenza Vaccine Customer List
Table 64. Global Injection Influenza Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Injection Influenza Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Injection Influenza Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Injection Influenza Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Injection Influenza Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Injection Influenza Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Injection Influenza Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Injection Influenza Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Injection Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Injection Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Injection Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Injection Influenza Vaccine Product Portfolios and Specifications
Table 95. Viatris Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Injection Influenza Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Injection Influenza Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Injection Influenza Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Injection Influenza Vaccine Product Portfolios and Specifications
Table 115. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. Jiangsu GDK Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu GDK Injection Influenza Vaccine Product Portfolios and Specifications
Table 120. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Jiangsu GDK Main Business
Table 122. Jiangsu GDK Latest Developments
Table 123. KM Biologics Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. KM Biologics Injection Influenza Vaccine Product Portfolios and Specifications
Table 125. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. KM Biologics Main Business
Table 127. KM Biologics Latest Developments
Table 1. Injection Influenza Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Injection Influenza Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Injection Influenza Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Injection Influenza Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Injection Influenza Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Injection Influenza Vaccine Revenue by Application (2019-2024)
Table 13. Global Injection Influenza Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Injection Influenza Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Injection Influenza Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Injection Influenza Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Injection Influenza Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Injection Influenza Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Injection Influenza Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Injection Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Injection Influenza Vaccine Products Offered
Table 22. Injection Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Injection Influenza Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Injection Influenza Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Injection Influenza Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Injection Influenza Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Injection Influenza Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Injection Influenza Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Injection Influenza Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Injection Influenza Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Injection Influenza Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Injection Influenza Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Injection Influenza Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Injection Influenza Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Injection Influenza Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Injection Influenza Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Injection Influenza Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Injection Influenza Vaccine
Table 58. Key Market Challenges & Risks of Injection Influenza Vaccine
Table 59. Key Industry Trends of Injection Influenza Vaccine
Table 60. Injection Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Injection Influenza Vaccine Distributors List
Table 63. Injection Influenza Vaccine Customer List
Table 64. Global Injection Influenza Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Injection Influenza Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Injection Influenza Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Injection Influenza Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Injection Influenza Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Injection Influenza Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Injection Influenza Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Injection Influenza Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Injection Influenza Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Injection Influenza Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Injection Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Injection Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Injection Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Injection Influenza Vaccine Product Portfolios and Specifications
Table 95. Viatris Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Injection Influenza Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Injection Influenza Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Injection Influenza Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Injection Influenza Vaccine Product Portfolios and Specifications
Table 115. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. Jiangsu GDK Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu GDK Injection Influenza Vaccine Product Portfolios and Specifications
Table 120. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Jiangsu GDK Main Business
Table 122. Jiangsu GDK Latest Developments
Table 123. KM Biologics Basic Information, Injection Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. KM Biologics Injection Influenza Vaccine Product Portfolios and Specifications
Table 125. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. KM Biologics Main Business
Table 127. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Injection Influenza Vaccine
Figure 2. Injection Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injection Influenza Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Injection Influenza Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Injection Influenza Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Injection Influenza Vaccine Sales Market Share by Type in 2023
Figure 12. Global Injection Influenza Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Injection Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Injection Influenza Vaccine Market: 6 Months to 3 Years (2019-2024) & (K Units)
Figure 15. Injection Influenza Vaccine Consumed in > 3 Years
Figure 16. Global Injection Influenza Vaccine Market: > 3 Years (2019-2024) & (K Units)
Figure 17. Global Injection Influenza Vaccine Sales Market Share by Application (2023)
Figure 18. Global Injection Influenza Vaccine Revenue Market Share by Application in 2023
Figure 19. Injection Influenza Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Injection Influenza Vaccine Sales Market Share by Company in 2023
Figure 21. Injection Influenza Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Injection Influenza Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Injection Influenza Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Injection Influenza Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Injection Influenza Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Injection Influenza Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Injection Influenza Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Injection Influenza Vaccine
Figure 72. Industry Chain Structure of Injection Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Injection Influenza Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Injection Influenza Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Injection Influenza Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Injection Influenza Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Injection Influenza Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Injection Influenza Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Injection Influenza Vaccine
Figure 2. Injection Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injection Influenza Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Injection Influenza Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Injection Influenza Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Injection Influenza Vaccine Sales Market Share by Type in 2023
Figure 12. Global Injection Influenza Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Injection Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Injection Influenza Vaccine Market: 6 Months to 3 Years (2019-2024) & (K Units)
Figure 15. Injection Influenza Vaccine Consumed in > 3 Years
Figure 16. Global Injection Influenza Vaccine Market: > 3 Years (2019-2024) & (K Units)
Figure 17. Global Injection Influenza Vaccine Sales Market Share by Application (2023)
Figure 18. Global Injection Influenza Vaccine Revenue Market Share by Application in 2023
Figure 19. Injection Influenza Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Injection Influenza Vaccine Sales Market Share by Company in 2023
Figure 21. Injection Influenza Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Injection Influenza Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Injection Influenza Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Injection Influenza Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Injection Influenza Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Injection Influenza Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Injection Influenza Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Injection Influenza Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Injection Influenza Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Injection Influenza Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Injection Influenza Vaccine
Figure 72. Industry Chain Structure of Injection Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Injection Influenza Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Injection Influenza Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Injection Influenza Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Injection Influenza Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Injection Influenza Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Injection Influenza Vaccine Revenue Market Share Forecast by Application (2025-2030)
